Glycogen storage disease type II: Difference between revisions
No edit summary |
Irfan Dotani (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}}; {{AE}} | |||
{{PleaseHelp}} | |||
{{Infobox_Disease | | {{Infobox_Disease | | ||
Name = {{PAGENAME}} | | Name = {{PAGENAME}} | | ||
Line 18: | Line 22: | ||
==[[Glycogen storage disease type II overview|Overview]]== | ==[[Glycogen storage disease type II overview|Overview]]== | ||
==[[Glycogen storage disease type II historical perspective|Historical Perspective]]== | ==[[Glycogen storage disease type II historical perspective|Historical Perspective]]== | ||
==[[Glycogen storage disease type II classification|Classification]]== | ==[[Glycogen storage disease type II classification|Classification]]== | ||
==[[Glycogen storage disease type II pathophysiology |Pathophysiology]]== | ==[[Glycogen storage disease type II pathophysiology |Pathophysiology]]== | ||
==[[Glycogen storage disease type II causes|Causes]]== | ==[[Glycogen storage disease type II causes|Causes]]== | ||
==[[Glycogen storage disease type II differential diagnosis|Differentiating Glycogen storage disease type I from other Diseases]]== | ==[[Glycogen storage disease type II differential diagnosis|Differentiating Glycogen storage disease type I from other Diseases]]== | ||
==[[Glycogen storage disease type II epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Glycogen storage disease type II epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[Glycogen storage disease type II risk factors|Risk Factors]]== | |||
==[[Glycogen storage disease type II screening|Screening]]== | |||
==[[Glycogen storage disease type II natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ==[[Glycogen storage disease type II natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ||
==Diagnosis== | ==Diagnosis== | ||
[[Glycogen storage disease type II history and symptoms|History and Symptoms]] | [[Glycogen storage disease type II physical examination|Physical Examination]] | [[Glycogen storage disease type II laboratory findings|Laboratory Findings]] | [[Glycogen storage disease type II electrocardiogram|Electrocardiogram]] | [[Glycogen storage disease type II echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Glycogen storage disease type II other diagnostic studies|Other Diagnostic Studies]] | [[Glycogen storage disease type II history and symptoms|History and Symptoms]] | [[Glycogen storage disease type II physical examination|Physical Examination]] | [[Glycogen storage disease type II laboratory findings|Laboratory Findings]] | [[Glycogen storage disease type II electrocardiogram|Electrocardiogram]] | [[Glycogen storage disease type II x ray|X Ray]] | [[Glycogen storage disease type II CT|CT]] | [[Glycogen storage disease type II MRI|MRI]] | [[Glycogen storage disease type II echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Glycogen storage disease type II other diagnostic studies|Other Diagnostic Studies]] | ||
==Treatment== | ==Treatment== | ||
[[Glycogen storage disease type II medical therapy|Medical Therapy]] | [[Glycogen storage disease type II cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Glycogen storage disease type II future or investigational therapies|Future or Investigational Therapies]] | [[Glycogen storage disease type II medical therapy|Medical Therapy]] | [[Glycogen storage disease type II surgery|Surgery]] | [[Glycogen storage disease type II primary prevention|Primary Prevention]] | [[Glycogen storage disease type II secondary prevention|Secondary Prevention]] | [[Glycogen storage disease type II cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Glycogen storage disease type II future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
:[[Glycogen storage disease type II case study one|Case #1]] | :[[Glycogen storage disease type II case study one|Case #1]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Hepatology]] | [[Category:Hepatology]] | ||
[[fr:Maladie de Pompe]] | [[fr:Maladie de Pompe]] |
Revision as of 15:07, 19 July 2016
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Glycogen storage disease type II | |
ICD-10 | E74.0 |
---|---|
ICD-9 | 271.0 |
OMIM | 232300 |
DiseasesDB | 5296 |
MeSH | D006009 |
Glycogen storage disease type II Microchapters |
Differentiating Glycogen storage disease type II from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glycogen storage disease type II On the Web |
American Roentgen Ray Society Images of Glycogen storage disease type II |
Directions to Hospitals Treating Glycogen storage disease type II |
Risk calculators and risk factors for Glycogen storage disease type II |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]
Synonyms and keywords: Glycogen storage disease type II; Pompe disease; acid maltase deficiency; glycogenosis type 2; alpha-1, 4-glucosidase deficiency
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Glycogen storage disease type I from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies